Inspire Medical Systems Stock-Based Compensation Growth & History (INSP)
Inspire Medical Systems's stock-based compensation was $130.3M for fiscal 2025.
View full Inspire Medical Systems company overviewInspire Medical Systems annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $130.3M | $14.3M | +12.29% |
| 2024 | 2024-12-31 | $116.0M | $33.5M | +40.67% |
| 2023 | 2023-12-31 | $82.5M | $30.5M | +58.69% |
| 2022 | 2022-12-31 | $52.0M | $25.8M | +98.53% |
| 2021 | 2021-12-31 | $26.2M | $13.4M | +104.24% |
| 2020 | 2020-12-31 | $12.8M | $6.6M | +106.83% |
| 2019 | 2019-12-31 | $6.2M | $5.0M | +408.37% |
| 2018 | 2018-12-31 | $1.2M | $976,000 | +401.65% |
| 2017 | 2017-12-31 | $243,000 | — | — |
Inspire Medical Systems quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $31.2M | −$10.5M | −25.18% |
| Q1 2026 | 2026-03-31 | $30.7M | −$367,000 | −1.18% |
| Q4 2025 | 2025-12-31 | $28.0M | −$1.2M | −4.05% |
| Q3 2025 | 2025-09-30 | $29.5M | $1.3M | +4.61% |
| Q2 2025 | 2025-06-30 | $41.7M | $9.4M | +29.10% |
| Q1 2025 | 2025-03-31 | $31.1M | $4.7M | +17.98% |
| Q4 2024 | 2024-12-31 | $29.2M | $6.3M | +27.73% |
| Q3 2024 | 2024-09-30 | $28.2M | $8.4M | +42.22% |
| Q2 2024 | 2024-06-30 | $32.3M | $10.7M | +49.77% |
| Q1 2024 | 2024-03-31 | $26.3M | $8.1M | +44.43% |
| Q4 2023 | 2023-12-31 | $22.8M | $7.8M | +52.32% |
| Q3 2023 | 2023-09-30 | $19.8M | $5.2M | +35.92% |
| Q2 2023 | 2023-06-30 | $21.6M | $8.9M | +70.37% |
| Q1 2023 | 2023-03-31 | $18.2M | $8.5M | +87.48% |
| Q4 2022 | 2022-12-31 | $15.0M | $8.0M | +113.39% |
| Q3 2022 | 2022-09-30 | $14.6M | $7.8M | +114.23% |
| Q2 2022 | 2022-06-30 | $12.7M | $6.3M | +99.64% |
| Q1 2022 | 2022-03-31 | $9.7M | $3.7M | +62.10% |
| Q4 2021 | 2021-12-31 | $7.0M | $3.2M | +82.41% |
| Q3 2021 | 2021-09-30 | $6.8M | $3.5M | +105.68% |
| Q2 2021 | 2021-06-30 | $6.3M | $3.4M | +118.43% |
| Q1 2021 | 2021-03-31 | $6.0M | $3.2M | +118.15% |
| Q4 2020 | 2020-12-31 | $3.9M | $2.0M | +103.59% |
| Q3 2020 | 2020-09-30 | $3.3M | $1.8M | +117.26% |
| Q2 2020 | 2020-06-30 | $2.9M | $1.5M | +109.00% |
| Q1 2020 | 2020-03-31 | $2.7M | $1.4M | +97.63% |
| Q4 2019 | 2019-12-31 | $1.9M | $1.4M | +261.95% |
| Q3 2019 | 2019-09-30 | $1.5M | $1.2M | +309.68% |
| Q2 2019 | 2019-06-30 | $1.4M | $1.1M | +416.36% |
| Q1 2019 | 2019-03-31 | $1.4M | $1.3M | +2429.09% |
| Q4 2018 | 2018-12-31 | $523,000 | $469,000 | +868.52% |
| Q3 2018 | 2018-09-30 | $372,000 | $291,000 | +359.26% |
| Q2 2018 | 2018-06-30 | $269,000 | $215,000 | +398.15% |
| Q1 2018 | 2018-03-31 | $55,000 | $1,000 | +1.85% |
| Q4 2017 | 2017-12-31 | $54,000 | — | — |
| Q3 2017 | 2017-09-30 | $81,000 | — | — |
| Q2 2017 | 2017-06-30 | $54,000 | — | — |
| Q1 2017 | 2017-03-31 | $54,000 | — | — |
Inspire Medical Systems stock-based compensation trends
Over the last five fiscal years, Inspire Medical Systems's stock-based compensation increased from $12.8M to $130.3M, a change of $117.4M. The latest reported quarter, Q2 2026, shows $31.2M.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Inspire Medical Systems source filings ↗